In vivo antihyperglycaemic and antihyperlipidemic activities and chemical constituents of Solanum anomalum
Open Access
- 20 May 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 151, 113153
Abstract
No abstract availableKeywords
Funding Information
- Keele University
This publication has 53 references indexed in Scilit:
- Effect of the administration of Solanum nigrum fruit on blood glucose, lipid profiles, and sensitivity of the vascular mesenteric bed to phenylephrine in streptozotocin-induced diabetic ratsMedical Science Monitor Basic Research, 2013
- Antidiabetic activities of ethanolic extract and fraction of Anthocleista djalonensisAsian Pacific Journal of Tropical Biomedicine, 2012
- The use of animal models in diabetes researchBritish Journal of Pharmacology, 2012
- Antidiabetic and antioxidant potential of β-sitosterol in streptozotocin-induced experimental hyperglycemiaJournal of Diabetes, 2011
- Central diabetes insipidus following digestionSolanum indicum L. concentrated solutionClinical Toxicology, 2008
- Appropriate calibration curve fitting in ligand binding assaysThe AAPS Journal, 2007
- Policosanol Inhibits Cholesterol Synthesis in Hepatoma Cells by Activation of AMP-KinaseThe Journal of Pharmacology and Experimental Therapeutics, 2006
- The Clinical Information Value of the Glycosylated Hemoglobin AssayNew England Journal of Medicine, 1984
- DIOSGENIN FROM SOLANUM AURANTIACOBACCATUM De WildPlanta Medica, 1977
- Diosgenin and β-Sitosterol: Isolation fromSolanum xanthocarpumTissue CulturesScience, 1968